Tropinina Olga / Shutterstock.com
Global IP offices are stepping up their efforts to improve patent harmonisation. John Alty, the group’s chair and chief executive of the UK Intellectual Property Office, explains more.
Group B+ members have agreed to step up their work in the area of patent harmonisation. The group, which comprises intellectual property representatives from more than 40 countries and intergovernmental organisations, was established to promote and facilitate global patent reform issues. It meets annually in the margins of the World Intellectual Property Organization (WIPO) General Assembly, and I have had the honour of chairing the group since 2011.
Harmonisation of patent legislation in different countries has always been a key focus of the group, which recognises the significant costs and risks to innovation and growth associated with a fragmented international framework. As businesses increasingly operate internationally, the need to adjust applications and behaviour to suit the particular features of each jurisdiction not only increases costs, but also increases the risk of errors due to unfamiliarity with different systems. This can potentially limit or even destroy the chances of obtaining a patent in some jurisdictions.
Third parties working in a particular field may also be affected, finding it difficult to determine the boundaries in which they are free to operate. Furthermore, offices turning to work-sharing with other offices to reduce duplication and help increase quality and efficiency will find the usefulness of doing so limited if their examiners are working to different conventions.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email tech support.
John Alty, Group B+, patent harmonisation, health, pharamceutical, IPO, Trans-Pacific Partnership,